MTOR and cancer: In many human cancers, mTOR signaling is upregulated, as it is in AD patients, and this upregulation leads to a decrease in autophagy (Li et al., 2005; Ballou and Lin, 2008; Bhutia et al., 2013; Francois et al., 2014).